164 related articles for article (PubMed ID: 10910271)
1. Early and late chemokine production correlates with cellular recruitment in cardiac allograft vasculopathy.
Yun JJ; Fischbein MP; Laks H; Fishbein MC; Espejo ML; Ebrahimi K; Irie Y; Berliner J; Ardehali A
Transplantation; 2000 Jun; 69(12):2515-24. PubMed ID: 10910271
[TBL] [Abstract][Full Text] [Related]
2. Rantes production during development of cardiac allograft vasculopathy.
Yun JJ; Fischbein MP; Laks H; Irie Y; Espejo ML; Fishbein MC; Berliner JA; Ardehali A
Transplantation; 2001 Jun; 71(11):1649-56. PubMed ID: 11435978
[TBL] [Abstract][Full Text] [Related]
3. Early chemokine cascades in murine cardiac grafts regulate T cell recruitment and progression of acute allograft rejection.
Morita K; Miura M; Paolone DR; Engeman TM; Kapoor A; Remick DG; Fairchild RL
J Immunol; 2001 Sep; 167(5):2979-84. PubMed ID: 11509648
[TBL] [Abstract][Full Text] [Related]
4. Combined blockade of the chemokine receptors CCR1 and CCR5 attenuates chronic rejection.
Yun JJ; Whiting D; Fischbein MP; Banerji A; Irie Y; Stein D; Fishbein MC; Proudfoot AE; Laks H; Berliner JA; Ardehali A
Circulation; 2004 Feb; 109(7):932-7. PubMed ID: 14757698
[TBL] [Abstract][Full Text] [Related]
5. Vascular cell adhesion molecule-1 is induced on vascular endothelia and medial smooth muscle cells in experimental cardiac allograft vasculopathy.
Ardehali A; Laks H; Drinkwater DC; Ziv E; Drake TA
Circulation; 1995 Aug; 92(3):450-6. PubMed ID: 7543379
[TBL] [Abstract][Full Text] [Related]
6. The role of MIG/CXCL9 in cardiac allograft vasculopathy.
Yun JJ; Fischbein MP; Whiting D; Irie Y; Fishbein MC; Burdick MD; Belperio J; Strieter RM; Laks H; Berliner JA; Ardehali A
Am J Pathol; 2002 Oct; 161(4):1307-13. PubMed ID: 12368204
[TBL] [Abstract][Full Text] [Related]
7. Chemokine expression in nerve allografts.
Midha R; Munro CA; Ramakrishna V; Matsuyama T; Gorczynski RM
Neurosurgery; 2004 Jun; 54(6):1472-8; discussion 1478-9. PubMed ID: 15157305
[TBL] [Abstract][Full Text] [Related]
8. Experimental cardiac allograft vasculopathy in mice.
Ardehali A; Billingsley A; Laks H; Drinkwater DC; Sorensen TJ; Drake TA
J Heart Lung Transplant; 1993; 12(5):730-5. PubMed ID: 8241210
[TBL] [Abstract][Full Text] [Related]
9. Induction of chemokine gene expression during allogeneic skin graft rejection.
Kondo T; Novick AC; Toma H; Fairchild RL
Transplantation; 1996 Jun; 61(12):1750-7. PubMed ID: 8685955
[TBL] [Abstract][Full Text] [Related]
10. Intraallograft chemokine RNA and protein during rejection of MHC-matched/multiple minor histocompatibility-disparate skin grafts.
Watarai Y; Koga S; Paolone DR; Engeman TM; Tannenbaum C; Hamilton TA; Fairchild RL
J Immunol; 2000 Jun; 164(11):6027-33. PubMed ID: 10820287
[TBL] [Abstract][Full Text] [Related]
11. Expression of chemokine genes during rejection and long-term acceptance of cardiac allografts.
Fairchild RL; VanBuskirk AM; Kondo T; Wakely ME; Orosz CG
Transplantation; 1997 Jun; 63(12):1807-12. PubMed ID: 9210509
[TBL] [Abstract][Full Text] [Related]
12. The contribution of chemokines and chemokine receptors to the rejection of fetal proislet allografts.
Solomon MF; Kuziel WA; Simeonovic CJ
Cell Transplant; 2004; 13(5):503-14. PubMed ID: 15565863
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of the IFN-gamma-inducible CXCR3-binding chemokines, IFN-inducible protein 10, monokine induced by IFN, and IFN-inducible T cell alpha chemoattractant in human cardiac allografts: association with cardiac allograft vasculopathy and acute rejection.
Zhao DX; Hu Y; Miller GG; Luster AD; Mitchell RN; Libby P
J Immunol; 2002 Aug; 169(3):1556-60. PubMed ID: 12133984
[TBL] [Abstract][Full Text] [Related]
14. T-cell depletion eliminates the development of cardiac allograft vasculopathy in mice rendered tolerant by the induction of mixed chimerism.
Uehara S; Chase CM; Colvin RB; Madsen JC; Russell PS
Transplant Proc; 2006 Dec; 38(10):3169-71. PubMed ID: 17175214
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-16 deficiency suppresses the development of chronic rejection in murine cardiac transplantation model.
Kimura N; Itoh S; Nakae S; Axtell RC; Velotta JB; Bos EJ; Merk DR; Gong Y; Okamura H; Nagamine CM; Adachi H; Kornfeld H; Robbins RC; Fischbein MP
J Heart Lung Transplant; 2011 Dec; 30(12):1409-17. PubMed ID: 22055099
[TBL] [Abstract][Full Text] [Related]
16. CD8+ lymphocytes augment chronic rejection in a MHC class II mismatched model.
Fischbein MP; Yun J; Laks H; Irie Y; Fishbein MC; Espejo M; Bonavida B; Ardehali A
Transplantation; 2001 Apr; 71(8):1146-53. PubMed ID: 11374417
[TBL] [Abstract][Full Text] [Related]
17. Early increased chemokine expression and production in murine allogeneic skin grafts is mediated by natural killer cells.
Kondo T; Morita K; Watarai Y; Auerbach MB; Taub DD; Novick AC; Toma H; Fairchild RL
Transplantation; 2000 Mar; 69(5):969-77. PubMed ID: 10755559
[TBL] [Abstract][Full Text] [Related]
18. Chemokine receptor blockade with a synthetic nonpeptide compound attenuates cardiac allograft vasculopathy.
Bastani S; Sherman W; Schnickel GT; Hsieh GR; Bhatia R; Fishbein MC; Ardehali A
Transplantation; 2009 Oct; 88(8):995-1001. PubMed ID: 19855245
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of chemokine receptor CCR2 and CCR5 expression contributes to simvastatin-induced attenuation of cardiac allograft vasculopathy.
Yin R; Zhu J; Shao H; Cheng X; Feng X; Li Z; Jing H
J Heart Lung Transplant; 2007 May; 26(5):485-93. PubMed ID: 17449418
[TBL] [Abstract][Full Text] [Related]
20. The chemokine and chemokine receptor profile of infiltrating cells in the wall of arteries with cardiac allograft vasculopathy is indicative of a memory T-helper 1 response.
van Loosdregt J; van Oosterhout MF; Bruggink AH; van Wichen DF; van Kuik J; de Koning E; Baan CC; de Jonge N; Gmelig-Meyling FH; de Weger RA
Circulation; 2006 Oct; 114(15):1599-607. PubMed ID: 17015796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
